Saam Dilmaghani

Saam Dilmaghani

Auto-generated profile, based on publicly available information

Saam Dilmaghani

Clinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R.), Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2023 in Gut
Verified
Journal Article
Closed access
PDF file
MCMichael Camilleri
Michael Camilleri
TZTing Zheng
Ting Zheng
KVKia Vosoughi
Kia Vosoughi
CLCamille Lupianez-Merly
Camille Lupianez-Merly
DEDeborah Eckert
Deborah Eckert
SDSaam Dilmaghani
Saam Dilmaghani
Objective: Symptoms in gastroparesis (Gp) and functional dyspepsia (FD) overlap; using egg protein substitute to measure gastric emptying of solids (GES), ~40% of patients are reclassified from Gp to FD, and vice versa. Our aim was to assess inter-individual and intra-individual coefficients of variation (COV) in GES in symptomatic patients with Gp or FD with documented slow or normal GES, respectively.Design: Scintigraphic GES (T1/2and GE% at 2 and 4 hours) using a 320 kcal real egg meal (30% fat) was tested in the following: single measurements in 20 patients with diabetes mellitus (10 each type 1 and type 2); repeat GES to estimate COVintrameasured: 3 days apart in 9 Gp, 4 weeks apart in 21 Gp and 18 with FD with normal GE assigned to placebo and in 70 patients at 94.3 weeks (median) apart.Results: COVinterfor GE% at 4 hours and GE T1/2were respectively 14.2% and 23.5% in FD and 27.5% and 33% in Gp; COVintrafor GE% at 4 hours and GE T1/2up to 4 weeks apart were 23.4% and 37.9% in FD and 20.1% and 33% in Gp. GE% at 2 hours showed less consistent results. However, >85% retained original diagnosis as normal or delayed. From clinical GES to baseline research for Gp group, repeat GES (after treatment) showed the COVintrafor GE% at 4 hours was 37.3% at median 94.3 weeks, with 26/70 changed diagnoses.Conclusion: The 320 kcal (30% fat) GES scintigraphic test provides consistent diagnosis in >85% and should be the standard test for suspected gastric emptying disorders.

10 October 2021 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
PDF file
SDSaam Dilmaghani
Saam Dilmaghani
JAJessica Atieh
Jessica Atieh
LKLehar Khanna
Lehar Khanna
EHEmily A. Hosfield
Emily A. Hosfield
MCMichael Camilleri
Michael Camilleri
DKDavid A. Katzka
David A. Katzka

20 April 2023 in Gastroenterology
Verified
Journal Article
Open access
JBJoelle BouSaba
Joelle BouSaba
MTMonique Torres
Monique Torres
SDSaam Dilmaghani
Saam Dilmaghani
WHW. Scott Harmsen
W. Scott Harmsen
LLLei Ling
Lei Ling
MCMichael Camilleri
Michael Camilleri

5 January 2023 in Gut
Verified
Journal Article
Closed access
PDF file
JBJoelle BouSaba
Joelle BouSaba
TZTing Zheng
Ting Zheng
SDSaam Dilmaghani
Saam Dilmaghani
SJStephen Johnson
Stephen Johnson
JCJun Chen
Jun Chen
MCMichael Camilleri
Michael Camilleri

17 March 2023 in Techniques and Innovations in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
SDSaam Dilmaghani
Saam Dilmaghani
NCNayantara Coelho-Prabhu
Nayantara Coelho-Prabhu

21 January 2025 in Clinical and Translational Gastroenterology
Verified
Journal Article
Open access
XWXiao Jing Wang
Xiao Jing Wang
LPLindsey Philpot
Lindsey Philpot
JEJon Ebbert
Jon Ebbert
SDSaam Dilmaghani
Saam Dilmaghani
CLConor Loftus
Conor Loftus
OPOlafur Palsson
Olafur Palsson
INTRODUCTION: Abdominal bloating is a difficult symptom to treat. Hypnotherapy and diaphragmatic intervention have separately shown benefit on bloating in prior work but have not been united into a single intervention. We aimed to obtain data on the potential therapeutic impact of a novel audio-recorded bloating treatment for bloating integrating hypnosis and diaphragmatic breathing, with proposed synergistic effect. METHODS: Patients with nonorganic bowel disorders with predominant bloating symptoms completed a digitally delivered 7-session audio-recorded hypnotherapy program without clinician involvement. The intervention combined bloating-targeted hypnotic suggestions and guided diaphragmatic breathing delivered under hypnosis, and was supplemented with interval self-guided breathing exercises. Participants completed online REDCap assessments at baseline, midtreatment, at end of treatment, and 3-month follow-up, evaluating symptom severity, gastrointestinal symptom-specific anxiety, overall anxiety/depression, and quality of life. Outcomes were assessed in an intention-to-treat manner with repeated measures analysis of variances (ANOVAs) with Bonferroni-adjusted pairwise post hoc tests. RESULTS: Of 23 patients who started treatment, 22 (95.6%) completed follow-up. Bloating severity on Irritable Bowel Syndrome-Symptom Severity Scale and Patient Assessment of Upper Gastrointestinal Symptom Severity Index showed reduction in bloating with large effect sizes (Cohen d of ∼0.8) at the end of treatment, as did Visceral Sensitivity Index bloating-related anxiety. At the end of treatment, 16 patients (69.6%) were Irritable Bowel Syndrome-Symptom Severity Scale treatment responders (≥30% symptom reduction) on bloating and 17 (73.9%) on overall bowel symptom severity. Anxiety, depression, and quality-of-life scores were unchanged. Outcome measures were fully maintained at the 3-month follow-up. DISCUSSION: Results suggest the therapeutic utility of a new cost-effective self-administered bloating intervention. A randomized controlled trial is planned to confirm these therapeutic effects.